Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herman, W. H.
Right arrow Articles by Halter, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herman, W. H.
Right arrow Articles by Halter, J. B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 43, Issue 1 40-46, Copyright © 1994 by American Diabetes Association


ARTICLES

Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree

WH Herman, SS Fajans, FJ Ortiz, MJ Smith, J Sturis, GI Bell, KS Polonsky and JB Halter
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0354.

Maturity-onset diabetes of the young (MODY) is a form of non-insulin-dependent diabetes mellitus (NIDDM) associated with autosomal-dominant inheritance. In the RW pedigree, MODY is associated with polymorphic DNA markers on chromosome 20q. To determine the early abnormalities of insulin action and insulin secretion in MODY, we studied nondiabetic members of the RW pedigree with and without the gene marker. Six nondiabetic marker-negative and 5 nondiabetic marker-positive members of the RW pedigree were studied, as were 4 diabetic marker-positive family members. Unrelated, young, healthy subjects served as comparison groups. Insulin action and insulin secretion were assessed with a frequently sampled intravenous glucose tolerance test. Insulin secretion was further assessed during constant glucose infusion by deconvolution of plasma C-peptide and by pulse analysis. The nondiabetic marker-positive group had normal sensitivity to insulin and unimpaired acute insulin response to intravenous glucose (AIRglu). However, the nondiabetic marker-positive group had decreased mean plasma C-peptide concentration and reduced absolute amplitude of insulin secretory oscillations during prolonged glucose infusion. These responses to prolonged glucose infusion were similar to those observed in the diabetic group. No alterations of insulin secretion were observed in the nondiabetic marker-negative family members. Deranged and deficient insulin secretion, and not insulin resistance, appears to be the genetic or primary abnormality that characterizes nondiabetic individuals who are predisposed to MODY in the RW pedigree.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
I. M. Libman, M. Pietropaolo, S. A. Arslanian, R. E. LaPorte, and D. J. Becker
Evidence for Heterogeneous Pathogenesis of Insulin-Treated Diabetes in Black and White Children
Diabetes Care, October 1, 2003; 26(10): 2876 - 2882.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Diabetes Care, January 1, 2003; 26(90001): s5 - 20.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Bartoov-Shifman, R. Hertz, H. Wang, C. B. Wollheim, J. Bar-Tana, and M. D. Walker
Activation of the Insulin Gene Promoter through a Direct Effect of Hepatocyte Nuclear Factor 4alpha
J. Biol. Chem., July 12, 2002; 277(29): 25914 - 25919.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Vague and L. Nguyen
Rationale and Methods for the Estimation of Insulin Secretion in a Given Patient: From Research to Clinical Practice
Diabetes, February 1, 2002; 51(90001): S240 - 244.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. M. Clark Jr., M. H. Chin, S. N. Davis, E. Fisher, R. G. Hiss, D. G. Marrero, E. A. Walker, and J. Wylie-Rosett
Incorporating the Results of Diabetes Research Into Clinical Practice: Celebrating 25 years of Diabetes Research and Training Center translation research
Diabetes Care, December 1, 2001; 24(12): 2134 - 2142.
[Full Text] [PDF]


Home page
Br Med BullHome page
A. L Fowden and D. J Hill
Intra-uterine programming of the endocrine pancreas
Br. Med. Bull., November 1, 2001; 60(1): 123 - 142.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. S. Fajans, G. I. Bell, and K. S. Polonsky
Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young
N. Engl. J. Med., September 27, 2001; 345(13): 971 - 980.
[Full Text] [PDF]


Home page
DiabetesHome page
J. Westerlund and P. Bergsten
Glucose Metabolism and Pulsatile Insulin Release From Isolated Islets
Diabetes, August 1, 2001; 50(8): 1785 - 1790.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Grimberg, R.J. Ferry Jr., A. Kelly, S. Koo-McCoy, K. Polonsky, B. Glaser, M.A. Permutt, L. Aguilar-Bryan, D. Stafford, P.S. Thornton, et al.
Dysregulation of Insulin Secretion in Children With Congenital Hyperinsulinism due to Sulfonylurea Receptor Mutations
Diabetes, February 1, 2001; 50(2): 322 - 328.
[Abstract] [Full Text]


Home page
J. Bacteriol.Home page
H. Jiang, I. Medintz, B. Zhang, and C. A. Michels
Metabolic Signals Trigger Glucose-Induced Inactivation of Maltose Permease in Saccharomyces
J. Bacteriol., February 1, 2000; 182(3): 647 - 654.
[Abstract] [Full Text]


Home page
The Diabetes EducatorHome page
E. A. Cabanas
Maturity-Onset Diabetes of the Young: Recent Findings Indicate Insulin Resistance/Obesity Are Not Factors
The Diabetes Educator, January 1, 1998; 24(4): 477 - 480.
[PDF]


Home page
NEJMHome page
K. S. Polonsky, J. Sturis, and G. I. Bell
Non-Insulin-Dependent Diabetes Mellitus -- A Genetically Programmed Failure of the Beta Cell to Compensate for Insulin Resistance
N. Engl. J. Med., March 21, 1996; 334(12): 777 - 783.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1994 by the American Diabetes Association.